Your browser doesn't support javascript.
loading
Decitabine enhances cytotoxic effect of T cells with an anti-CD19 chimeric antigen receptor in treatment of lymphoma.
Li, Sujun; Xue, Lei; Wang, Min; Qiang, Ping; Xu, Hui; Zhang, Xuhan; Kang, Wenyao; You, Fengtao; Xu, Hanying; Wang, Yu; Liu, Xin; Yang, Lin; Wang, Xingbing.
Afiliação
  • Li S; Department of Hematology of Anhui Provincial Hospital, Anhui Medical University, Hefei, Anhui, People's Republic of China.
  • Xue L; Department of Hematology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, People's Republic of China.
  • Wang M; Department of Quality Assurance, PersonGen-Anke Cellular Therapeutics Co., Ltd, China, Hefei, People's Republic of China.
  • Qiang P; Department of Hematology of Anhui Provincial Hospital, Anhui Medical University, Hefei, Anhui, People's Republic of China.
  • Xu H; Department of Hematology of Anhui Provincial Hospital, Anhui Medical University, Hefei, Anhui, People's Republic of China.
  • Zhang X; Department of Hematology of Anhui Provincial Hospital, Anhui Medical University, Hefei, Anhui, People's Republic of China.
  • Kang W; Department of Quality Assurance, PersonGen-Anke Cellular Therapeutics Co., Ltd, China, Hefei, People's Republic of China.
  • You F; Department of Quality Assurance, PersonGen-Anke Cellular Therapeutics Co., Ltd, China, Hefei, People's Republic of China.
  • Xu H; Department of Quality Assurance, PersonGen-Anke Cellular Therapeutics Co., Ltd, China, Hefei, People's Republic of China.
  • Wang Y; Department of Quality Assurance, PersonGen-Anke Cellular Therapeutics Co., Ltd, China, Hefei, People's Republic of China.
  • Liu X; Department of Hematology of Anhui Provincial Hospital, Anhui Medical University, Hefei, Anhui, People's Republic of China.
  • Yang L; Department of Quality Assurance, PersonGen-Anke Cellular Therapeutics Co., Ltd, China, Hefei, People's Republic of China.
  • Wang X; Department of Hematology of Anhui Provincial Hospital, Anhui Medical University, Hefei, Anhui, People's Republic of China.
Onco Targets Ther ; 12: 5627-5638, 2019.
Article em En | MEDLINE | ID: mdl-31372000

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2019 Tipo de documento: Article